Company Briacell Therapeutics Corp Toronto S.E.
Equities
CA10778Y1043
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 31/10/16 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 31/01/16 |
Chief Tech/Sci/R&D Officer | 53 | 30/04/21 | |
Chief Tech/Sci/R&D Officer | 62 | 15/02/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 09/05/16 |
Marc Lustig
BRD | Director/Board Member | 51 | 30/08/21 |
Rebecca Taub
BRD | Director/Board Member | 71 | 06/03/18 |
Director/Board Member | 66 | 17/03/19 | |
William Williams
CEO | Chief Executive Officer | 68 | 31/10/16 |
Jane Gross
BRD | Director/Board Member | 67 | 31/10/21 |
Chairman | 39 | 03/02/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,284,661 | 15,440,125 ( 84.44 %) | 0 | 84.44 % |
Company contact information
BriaCell Therapeutics Corp.
Bellevue Centre 235 -15th Street
V7T 2X1, West Vancouver
+604 921 1810
http://www.briacell.comSector
1st Jan change | Capi. | |
---|---|---|
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+2.71% | 22.82B | |
-9.95% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |